Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 1/2009

01-01-2009 | Melanomas

Multidisciplinary Team-Working Indicators of Good Practice in the Clinical Management of EGFR-Inhibitor Dermatologic Toxicities

Authors: Ausilia Maria Manganoni, Camillo Farisoglio, Vittorio Ferrari, Alberto Zaniboni, Giordano Beretta, Fausto Meriggi, Piergiacomo Calzavara-Pinton

Published in: Annals of Surgical Oncology | Issue 1/2009

Login to get access

Excerpt

To the Editor …
Literature
1.
Segaert S, Tabernero J, Chosidow O, et al. The management of skin reactions in cancer patients receiving epidermal growth factor receptor targeted therapies. J Dtsch Dermatol Ges. 2005;3;599–606CrossRefPubMed
2.
Saltz LB, Meropol NJ, Loehrer PJ, Needle MN, Kopit J, Mayer RJ. Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor. J Clin Oncol. 2004;22:1201–8CrossRefPubMed
3.
Eaby B, Culkin A, Lacouture ME. An interdisciplinary consensus on managing skin reactions associated with human epidermal growth factor receptor inhibitors. Clin J Oncol Nurs. 2008;12:283–90CrossRefPubMed
4.
Monti M, Motta S. Clinical management of cutaneous toxicity of anti-EGFR agents. Int J Biol Markers. 2007;22(1 suppl 4):S53–61
Metadata
Title
Multidisciplinary Team-Working Indicators of Good Practice in the Clinical Management of EGFR-Inhibitor Dermatologic Toxicities
Authors
Ausilia Maria Manganoni
Camillo Farisoglio
Vittorio Ferrari
Alberto Zaniboni
Giordano Beretta
Fausto Meriggi
Piergiacomo Calzavara-Pinton
Publication date
01-01-2009
Publisher
Springer New York
Published in
Annals of Surgical Oncology / Issue 1/2009
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-008-0200-z

Other articles of this Issue 1/2009

Annals of Surgical Oncology 1/2009 Go to the issue

Gynecologic Oncology

Primary Vaginal Reconstruction at the Time of Pelvic Exenteration for Gynecologic Cancer: Morbidity Revisited

Healthcare Policy and Outcomes

Validation of the Mexican Spanish Version of the EORTC C30 and STO22 Questionnaires for the Evaluation of Health-Related Quality of Life in Patients with Gastric Cancer

Melanomas

Positive Nonsentinel Node Status Predicts Mortality in Patients with Cutaneous Melanoma

Gastrointestinal Oncology

Perineal Healing and Survival After Anal Cancer Salvage Surgery: 10-Year Experience with Primary Perineal Reconstruction Using the Vertical Rectus Abdominis Myocutaneous (VRAM) Flap

Head and Neck Oncology

Risk Stratification of Patients with Oral Cavity Squamous Cell Carcinoma and Contralateral Neck Recurrence Following Radical Surgery

Gastrointestinal Oncology

Prognostic Significance of the Number of Metastatic Lymph Nodes: Is UICC/TNM Node Classification Perfectly Suitable for Early Gastric Cancer?